{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T00:13:34Z","timestamp":1784765614139,"version":"3.55.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,12,1]],"date-time":"2011-12-01T00:00:00Z","timestamp":1322697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1016\/j.molimm.2011.09.019","type":"journal-article","created":{"date-parts":[[2011,10,22]],"date-time":"2011-10-22T09:40:41Z","timestamp":1319276441000},"page":"474-482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Unexpected recombinations in single chain bispecific anti-CD3\u2013anti-CD33 antibodies can be avoided by a novel linker module"],"prefix":"10.1016","volume":"49","author":[{"given":"Slava","family":"Stamova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Cartellieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Feldmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Koristka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holger","family":"Bartsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia C.","family":"Bippes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekka","family":"Wehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"von Bonin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bornh\u00e4user","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Ehninger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bachmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.molimm.2011.09.019_bib0005","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s11095-008-9767-0","article-title":"Insertion of the designed helical linker led to increased expression of tf-based fusion proteins","volume":"26","author":"Amet","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0010","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1182\/blood.V62.1.124.124","article-title":"Myeloid-associated differentiation antigens on stem cells and their progeny identified by monoclonal antibodies","volume":"62","author":"Andrews","year":"1983","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2011.09.019_bib0015","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1182\/blood.V68.5.1030.1030","article-title":"The L4F3 antigen is expressed by unipotent and multipotent colony-forming cells but not by their precursors","volume":"68","author":"Andrews","year":"1986","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2011.09.019_bib0020","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1158\/0008-5472.CAN-09-0547","article-title":"Bispecific T-cell engaging antibodies for cancer therapy","volume":"15","author":"Baeuerle","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0025","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.1158545","article-title":"Tumor regression in cancer patients by very low doses of a T cell-engaging antibody","volume":"321","author":"Bargou","year":"2008","journal-title":"Science"},{"key":"10.1016\/j.molimm.2011.09.019_bib0030","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.leukres.2006.05.026","article-title":"Analysis of the CD33-related siglec family reveals that Siglec-9 is an endocytic receptor expressed on subsets of acute myeloid leukemia cells and absent from normal hematopoietic progenitors","volume":"31","author":"Biedermann","year":"2007","journal-title":"Leuk. Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0035","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.4049\/jimmunol.171.2.1070","article-title":"Induction of human T lymphocyte cytotoxicity and inhibition of tumor growth by tumor-specific diabody-based molecules secreted from gene-modified bystander cells","volume":"171","author":"Blanco","year":"2003","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2011.09.019_bib0040","doi-asserted-by":"crossref","first-page":"e16315","DOI":"10.1371\/journal.pone.0016315","article-title":"A novel modular antigen delivery system for immuno targeting of human 6-sulfo LacNAc-positive blood dendritic cells (SlanDCs)","volume":"6","author":"Bippes","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.molimm.2011.09.019_bib0045","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1158\/1078-0432.CCR-08-0894","article-title":"Gemtuzumab ozogamicin as part of reduced-intensity conditioning for allogeneic hematopoietic cell transplantation in patients with relapsed acute myeloid leukemia","volume":"14","author":"Bornh\u00e4user","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0050","first-page":"1490","article-title":"Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia","volume":"7","author":"Bross","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-4827(89)90038-4","article-title":"Identification of La ribonucleoproteins as a component of interchromatin granules","volume":"185","author":"Carmo-Fonseca","year":"1989","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0060","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1016\/j.molimm.2009.07.014","article-title":"Anti-nuclear antibody reactivity in lupus may be partly hard-wired into the primary B-cell repertoire","volume":"46","author":"Chang","year":"2009","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.molimm.2011.09.019_bib0065","first-page":"1319","article-title":"Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody 251\u00d722 (anti-CD33\u00d7anti-CD64)","volume":"1","author":"Chen","year":"1995","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0070","doi-asserted-by":"crossref","first-page":"888","DOI":"10.4049\/jimmunol.165.2.888","article-title":"Treatment of human B cell lymphoma xenografts with a CD3\u00d7CD19 diabody and T cells","volume":"165","author":"Cochlovius","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2011.09.019_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.blre.2008.03.002","article-title":"Acute myeloid leukemia in the elderly: conventional and novel treatment approaches","volume":"22","author":"Craig","year":"2008","journal-title":"Blood Rev."},{"key":"10.1016\/j.molimm.2011.09.019_bib0080","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.leukres.2008.08.025","article-title":"Combination of rituximab with blinatumomab (MT103\/MEDI-538), a T cell-engaging CD19-\/CD3-bispecific antibody, for highly efficient lysis of human B lymphoma cells","volume":"33","author":"d\u2019Argouges","year":"2009","journal-title":"Leuk. Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0085","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.4049\/jimmunol.170.8.4397","article-title":"T cell costimulus-independent and very efficacious inhibition of tumor growth in mice bearing subcutaneous or leukemic human B cell lymphoma xenografts by a CD19-\/CD3-bispecific single-chain antibody construct","volume":"170","author":"Dreier","year":"2003","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.molimm.2011.09.019_bib0090","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/pros.21315","article-title":"Retargeting of T cells to prostate stem cell antigen expressing tumor cells: comparison of different antibody formats","volume":"71","author":"Feldmann","year":"2011","journal-title":"Prostate"},{"issue":"6","key":"10.1016\/j.molimm.2011.09.019_bib0095","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1002\/pros.21274","article-title":"Effective targeting of prostate cancer by lymphocytes redirected by a PSMA\u00d7CD3 bispecific single-chain diabody","volume":"71","author":"Fortm\u00fcller","year":"2011","journal-title":"Prostate"},{"key":"10.1016\/j.molimm.2011.09.019_bib0100","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0145-2126(84)90001-8","article-title":"A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells","volume":"8","author":"Griffin","year":"1984","journal-title":"Leuk. Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0105","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/0958-1669(93)90010-T","article-title":"Engineering bispecific antibodies","volume":"4","author":"Holliger","year":"1993","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.molimm.2011.09.019_bib0110","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nbt1142","article-title":"Engineered antibody fragments and the rise of single domains","volume":"23","author":"Holliger","year":"2005","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.molimm.2011.09.019_bib0115","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0969-2126(03)00121-7","article-title":"Structure of the C-terminal domain of human La protein reveals a novel RNA recognition motif coupled to a helical nuclear retention element","volume":"11","author":"Jacks","year":"2003","journal-title":"Structure"},{"key":"10.1016\/j.molimm.2011.09.019_bib0120","first-page":"106","article-title":"Cancer statistics, 2006","volume":"56","author":"Jemal","year":"2006","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.molimm.2011.09.019_bib0125","first-page":"277","article-title":"Cancer statistics, 2010","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.molimm.2011.09.019_bib0130","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/978-1-60327-302-2_14","article-title":"Generation of bispecific and tandem diabodies","volume":"562","author":"Kipriyanov","year":"2009","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.molimm.2011.09.019_bib0135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1745-7254.2005.00008.x","article-title":"Recombinant bispecific antibodies for cancer therapy","volume":"26","author":"Kontermann","year":"2005","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.molimm.2011.09.019_bib0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nprot.2006.105","article-title":"De novo production of antigen-specific suppressor cells in vivo","volume":"1","author":"Kretschmer","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.molimm.2011.09.019_bib0145","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1389-0344(01)00083-1","article-title":"De novo production of antigen-specific suppressor cells in vivo","volume":"18","author":"Kriangkum","year":"2001","journal-title":"Biomol. Eng."},{"key":"10.1016\/j.molimm.2011.09.019_bib0150","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4049\/jimmunol.155.1.219","article-title":"Preferential species-restricted heavy\/light chain pairing in rat\/mouse quadromas. Implications for a single-step purification of bispecific antibodies","volume":"155","author":"Lindhofer","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2011.09.019_bib0155","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/pros.20608","article-title":"Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells","volume":"67","author":"Morgenroth","year":"2007","journal-title":"Prostate"},{"key":"10.1016\/j.molimm.2011.09.019_bib0160","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.tips.2009.02.005","article-title":"Siglecs as targets for therapy in immune-cell-mediated disease","volume":"30","author":"O\u2019Reilly","year":"2009","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.molimm.2011.09.019_bib0165","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood.V79.9.2229.2229","article-title":"Human bone marrow depleted of CD33-positive cells mediates delayed but durable reconstitution of hematopoiesis: clinical trial of MY9 monoclonal antibody-purged autografts for the treatment of acute myeloid leukemia","volume":"79","author":"Robertson","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.molimm.2011.09.019_bib0170","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1158\/0008-5472.CAN-04-2637","article-title":"Eradication of tumors from a human colon cancer cell line and from ovarian cancer metastases in immunodeficient mice by a single-chain Ep-CAM-\/CD3-bispecific antibody construct","volume":"65","author":"Schlereth","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.molimm.2011.09.019_bib0175","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0378-1119(93)90378-G","article-title":"Isolation of rat cDNA clones coding for the autoantigen SS-B\/La: detection of species-specific variations","volume":"30","author":"Semsei","year":"1993","journal-title":"Gene"},{"key":"10.1016\/j.molimm.2011.09.019_bib0180","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1365-2141.1995.tb08406.x","article-title":"Potentiation of lysis of leukaemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells","volume":"89","author":"Silla","year":"1995","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.molimm.2011.09.019_bib0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1196\/annals.1443.011","article-title":"Basic and clinical immunology of Siglecs","volume":"1143","author":"von Gunten","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.molimm.2011.09.019_bib0190","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0022-1759(99)00184-2","article-title":"Universal PCR amplification of mouse immunoglobulin gene variable regions: the design of degenerate primers and an assessment of the effect of DNA polymerase 3\u2032 to 5\u2032 exonuclease activity","volume":"233","author":"Wang","year":"2000","journal-title":"J. Immunol. Methods"},{"key":"10.1016\/j.molimm.2011.09.019_bib0195","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/j.1398-9995.2006.01133.x","article-title":"Alteration and acquisition of Siglecs during in vitro maturation of CD34+ progenitors into human mast cells","volume":"61","author":"Yokoi","year":"2006","journal-title":"Allergy"}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589011007590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589011007590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T13:25:44Z","timestamp":1758979544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589011007590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12]]},"references-count":39,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["S0161589011007590"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2011.09.019","relation":{},"ISSN":["0161-5890"],"issn-type":[{"value":"0161-5890","type":"print"}],"subject":[],"published":{"date-parts":[[2011,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unexpected recombinations in single chain bispecific anti-CD3\u2013anti-CD33 antibodies can be avoided by a novel linker module","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2011.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}